Malmö, SE and Madison, WI, USA - Svar Life Science and Nimble Therapeutics today announced a collaboration to discover, develop, and commercialize diagnostic tests based on Nimble’s powerful and broadly applicable biomarker discovery engine and Svar’s strong in vitro diagnostic test development and commercialization expertise.